HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
A forum for researchers, students and applicants in the field of cyclodextrin technology
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who
Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent
RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of
Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19
Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use or development for
The science reported that the drug plitidepsin (aplidin), which has limited clinical approval, possesses antiviral activity (IC90 = 0.88 nM) 27.5-fold
Nature Microbiology reported on an orally efficacious ribonucleoside analogue inhibitor of influenza viruses, MK-4482/EIDD-2801, that was repurposed for use against
APNEWS reported: This exhaustive Alpha-Cyclodextrin market report provides a full holistic analysis [2012-2019], market size and time frame [2021-2030], emerging
A recent paper published in Anesthesia & Analgesia Journal evaluated the possible benefits of using aspirin in hospitalized COVID-19 patients